Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.
Pharmacoeconomics. 2023 Dec;41(12):1641-1655. doi: 10.1007/s40273-023-01305-3. Epub 2023 Aug 12.
Pharmacoeconomics. 2023.
PMID: 37572261
Free PMC article.
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland.
Barbier MC, Pardo E, Panje CM, Gautschi O, Lupatsch JE; Swiss Group for Clinical Cancer Research (SAKK).
Barbier MC, et al.
Eur J Health Econ. 2021 Jul;22(5):669-677. doi: 10.1007/s10198-021-01282-4. Epub 2021 Mar 21.
Eur J Health Econ. 2021.
PMID: 33745093
Free PMC article.
Item in Clipboard
Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs.
Zgraggen A, Stoffel ST, Barbier MC, Marbet UA.
Zgraggen A, et al. Among authors: barbier mc.
Z Gastroenterol. 2022 May;60(5):761-778. doi: 10.1055/a-1796-2471. Epub 2022 May 11.
Z Gastroenterol. 2022.
PMID: 35545112
Free PMC article.
Item in Clipboard
Cite
Cite